An atypical variant of fabry's disease in men with left ventricular hypertrophy

New England Journal of Medicine

Volumn 333, Issue 5, 1995, Pages 288-293

  Nakao, Shoichiro ^a   Takenaka, Toshihiro ^a   Maeda, Masato ^a   Kodama, Chihaya ^a   Tanaka, Akihiro ^a   Tahara, Minoru ^a   Yoshida, Aichi ^a   Kuriyama, Masaru ^a   Hayashibe, Hidemasa ^b   Sakuraba, Hitoshi ^b   Tanaka, Hiromitsu ^a  

^a Department of Internal Medicine ^*  (Japan)

^b KAGOSHIMA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA GALACTOSIDASE;

ADULT; AGED; ARTICLE; DIFFERENTIAL DIAGNOSIS; ENZYME DEFICIENCY; FABRY DISEASE; GENE MUTATION; HEART LEFT VENTRICLE HYPERTROPHY; HEART MUSCLE BIOPSY; HEMIZYGOSITY; HISTOPATHOLOGY; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ALPHA-GALACTOSIDASE; BASE SEQUENCE; DIAGNOSIS, DIFFERENTIAL; DNA; FABRY DISEASE; HUMAN; HYPERTROPHY, LEFT VENTRICULAR; MALE; MICROSCOPY, ELECTRON; MIDDLE AGE; MOLECULAR SEQUENCE DATA; MUTATION; MYOCARDIUM; RNA, MESSENGER; SUPPORT, NON-U.S. GOV'T;

EID: 0029023150     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJM199508033330504     Document Type: Article

References (34)

1. Desnick RJ, Ioannou YA, Eng CM. α-Galactosidase A deficiency: Fabry disease. In: Scriver CR, Beaudet AL, Sly WS, Valle D, eds. The metabolic and molecular bases of inherited disease. 7th ed. Vol. 2. New York: McGraw-Hill, 1995:2741-84.
2. Brady RO, Gal AE, Bradley RM, Martensson E, Warshaw AL, Laster L Enzymatic defect in Fabry's disease: ceramidetrihexosidase deficiency. N Engl J Med 1967; 276: 1163-1167
3. Desnick RJ, Allen KY, Desnick SJ, Raman MK, Bernlohr RW, Krivit W Fabry's disease: enzymatic diagnosis of hemizygotes and heterozygotes: α-galactosidase activities in plasma, serum, urine, and leukocytes. J Lab Clin Med 1973; 81: 157-171
4. Ferrans VJ, Hibbs RG, Burda CD The heart in Fabry's disease: a histochemical and electron microscopic study. Am J Cardiol 1969; 24: 95-110
5. Roudebush CP, Foerster JM, Bing OHL The abbreviated PR interval of Fabry's disease. N Engl J Med 1973; 289: 357-358
6. Becker AE, Schoorl R, Balk AG, van der Heide RM Cardiac manifestations of Fabry's disease: report of a case with mitral insufficiency and electrocardiographic evidence of myocardial infarction. Am J Cardiol 1975; 36: 829-835
7. Desnick RJ, Blieden LC, Sharp HL, Hofschire PJ, Moller JH Cardiac valvular anomalies in Fabry disease: clinical, morphologic, and biochemical studies. Circulation 1976; 54: 818-825
8. Mehta J, Tuna N, Moller JH, Desnick RJ Electrocardiographic and vectorcardiographic abnormalities in Fabry's disease. Am Heart J 1977; 93: 699-705
9. Matsui S, Murakami E, Takekoshi N, Hiramaru Y, Kin T Cardiac manifestations of Fabry's disease: report of a case with pulmonary regurgitation diagnosed on the basis of endomyocardial biopsy findings. Jpn Circ J 1977; 41: 1023-1036
10. Bass JL, Shrivastava S, Grabowski GA, Desnick RJ, Moller JH The M-mode echocardiogram in Fabry's disease. Am Heart J 1980; 100: 807-812
11. Colucci WS, Lorell BH, Schoen FJ, Warhol MJ, Grossman W Hypertrophic obstructive cardiomyopathy due to Fabry's disease. N Engl J Med 1982; 307: 926-928
12. Kuhn H, Kohler E, Hort W, Frenzel H Concealed myocardial storage disease (Fabry's disease): pitfalls in the diagnosis of hypertrophic nonobstructive cardiomyopathy. Circulation 1982; 66: Suppl II: II-117 abstract.
13. Sakuraba H, Yanagawa Y, Igarashi T, Cardiovascular manifestations in Fabry's disease: a high incidence of mitral valve prolapse in hemizygotes and heterozygotes. Clin Genet 1986; 29: 276-283
14. Goldman ME, Cantor R, Schwartz MF, Baker M, Desnick RJ Echocardiographic abnormalities and disease severity in Fabry's disease. J Am Coll Cardiol 1986; 7: 1157-1161
15. Yanagawa Y, Sakuraba H Cardiovascular manifestations in Fabry's disease -- age-related changes in hemizygotes and heterozygotes. Acta Paediatr Jpn 1988; 30: 38-48
16. Elleder M, Bradova V, Smid F, Cardiocyte storage and hypertrophy as a sole manifestation of Fabry's disease: report on a case simulating hypertrophic non-obstructive cardiomyopathy. Virchows Arch A Pathol Anat Histopathol 1990; 417: 449-455
17. Ogawa K, Sugamata K, Funamoto N, Restricted accumulation of globotriaosylceramide in the hearts of atypical cases of Fabry's disease. Hum Pathol 1990; 21: 1067-1073
18. Nagao Y, Nakashima H, Fukuhara Y, Hypertrophic cardiomyopathy in late-onset variant of Fabry disease with high residual activity of α-galactosidase A. Clin Genet 1991; 39: 233-237
19. von Scheidt W, Eng CM, Fitzmaurice TF, An atypical variant of Fabry's disease with manifestations confined to the myocardium. N Engl J Med 1991; 324: 395-399
20. Fisher EA, Desnick RJ, Gordon RE, Eng CM, Griepp R, Goldman ME Fabry disease: an unusual cause of severe coronary disease in a young man. Ann Intern Med 1992; 117: 221-223
21. Ikari Y, Kuwako K, Yamaguchi T Fabry's disease with complete atrioventricular block: histological evidence of involvement of the conduction system. Br Heart J 1992; 68: 323-325
22. Felner JM. Echocardiography. In: Hurst JW, Schlant RC, Rackley CE, Sonnenblick EH, Wenger NK, eds. The heart, arteries and veins. 7th ed. New York: McGraw-Hill, 1990:1990-2035.
23. Mayes JS, Scheerer JB, Sifers RN, Donaldson ML Differential assay for lysosomal alpha-galactosidase in human tissues and its application to Fabry's disease. Clin Chim Acta 1981; 112: 247-251
24. Anderson MA, Gusella JF Use of cyclosporin A in establishing Epstein-Barr virus-transformed human lymphoblastoid cell lines. In Vitro 1984; 20: 856-858
25. Davis LG, Dibner MD, Battey JF. Basic methods in molecular biology. New York: Elsevier, 1986:130-42.
26. Sambrook J, Fritsch EF, Maniatis T. Molecular cloning: a laboratory manual. 2nd ed. Cold Spring Harbor, N.Y.: Cold Spring Harbor Laboratory, 1989.
27. Eng CM, Resnick-Silverman LA, Niehaus DJ, Astrin KH, Desnick RJ Nature and frequency of mutations in the α-galactosidase A gene that cause Fabry disease. Am J Hum Genet 1993; 53: 1186-1197
28. Ishii S, Sakuraba H, Suzuki Y Point mutations in the upstream region of the α-galactosidase A gene exon 6 in an atypical variant of Fabry disease. Hum Genet 1992; 89: 29-32
29. Koide T, Ishiura M, Iwai K, A case of Fabry's disease in a patient with no α-galactosidase A activity caused by a single amino acid substitution of Pro-40 by Ser. FEBS Lett 1990; 259: 353-356
30. Ishii S, Kase R, Sakuraba H, Human α-galactosidase gene expression: significance of two peptide regions encoded by exons 1-2 and 6. Biochim Biophys Acta 1994; 1204: 265-270
31. Henry WL, Clark CE, Epstein SE Asymmetric septal hypertrophy: echocardiographic identification of the pathognomonic anatomic abnormality of IHSS. Circulation 1973; 47: 225-233
32. Webb JG, Sasson Z, Rakowski H, Liu P, Wigle ED Apical hypertrophic cardiomyopathy: clinical follow-up and diagnostic correlates. J Am Coll Cardiol 1990; 15: 83-90
33. Bishop DF, Kornreich R, Desnick RJ Structural organization of the human α-galactosidase A gene: further evidence for the absence of a 3' untranslated region. Proc Natl Acad Sci U S A 1988; 85: 3903-3907
34. Sakuraba H, Oshima A, Fukuhara Y, Identification of point mutations in the α-galactosidase A gene in classical and atypical hemizygotes with Fabry disease. Am J Hum Genet 1990; 47: 784-789